tirzepatide vs semaglutide weight loss study Cardiovascular outcomes of and for patients with type 2 diabetes in clinical practice Comparing Semaglutide vs Tirzepatide for

This structural variance significantly affects their interaction with melanocortin receptors in the body, thereby influencing their potential therapeutic impact and side effects [5]

A small percentage of patients lose significantly more

The adverse GI side effects only led to participants discontinuing their medication for 3% of patients on semaglutide 3 mg, 6% of patients on 7 mg semaglutide, 6% of patients on 14 mg semaglutide, and 3% of patients receiving dulaglutide (2)

Eligibility criteria for study selection We included studies that assessed adult men (aged 18 years) with functional hypogonadism associated with obesity or type 2 diabetes